Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Sixth, we could not directly control for patient adherence to medications due to limited medical adherence information captured in patient EHRs
Otherwise, you would have to pay for this privately
Start your intake Retatrutide is investigational, not available Retatrutide is an investigational once-weekly triple hormone receptor agonist under development by Eli Lilly, designed to activate the GIP, GLP-1, and glucagon pathways
Diabetes Metab J (2016) 40:354
US$ 23.55
US$ 20.55
US$ 26.04
US$ 25.21
US$ 26.08
US$ 23.24
US$ 25.97
US$ 23.68
